NEW YORK — At OSN New York 2015, Nicole R. Fram, MD, gives pearls on using the Hoffman pocket technique.
Uncategorized
Scientists find potential target for dry AMD
Results may lead to first drug targeting the blinding condition.Scientists have good news for patients who suffer from currently untreatable dry age-related macular degeneration (dry AMD).
Allergan signs licensing agreement with Mimetogen to develop, commercialize tavilermide for treatment of dry eye disease
Allergan plc, a leading global pharmaceutical company, today announced that its wholly owned subsidiary has entered into an exclusive licensing agreement with Mimetogen Pharmaceuticals, a clinical stage biotechnology company, to develop and commerciali…
Eleven Biotherapeutics Reports Third Quarter 2015 Financial Results
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Eleven Biotherapeutics Reports Third Quarter 2015 Financial Results. Management to host conference call today at 8:30 a.m. ET
Aerie Pharmaceuticals to Host Investor and Media Briefing During the 2015 American Academy of Ophthalmology Annual Meeting on November 13, 2015
IRVINE, Calif.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), today announced that the Company will host a live webcast in conjunction with its Investor and Media Briefing during the 2015 American Academy of Ophthalmology Meeting on Frida…
NovaBay Pharmaceuticals Completes 34 Patient Phase 2B Clinical Study
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on commercializing and developing non-antibiotic antimicrobial products for the global eye care market, announces plans to report results from a clinical study with its proprietary anti-microbial compound auriclosene (NVC-422) to reduce urinary catheter blockage and encrustation in patients with long-term indwelling urinary catheters in early December. Due to spinal cord inj